July 2020
SAFETY OBSERVER N169
22 PAGES
COVID-19 Guidance
New CIOMS DILI Guidance
FDA updates E2B Guidance
FDA updates REMS Guidance
EU PV Training Material
PUBLICATIONS / NUMBER 169
Stay on top of all key Pharmacovigilance Regulatory requirements
We do the search and bring you the regulatory information you need to achieve compliancein your Pharmacovigilance operations.
Back issues
Latest ReleaseSafety Observer 171FDA new COVID-19 Guidance
New FDA Draft Labeling Guidance
EMA consults on Registry Studies
MHRA to run free Brexit webinars
New PV Guidance in South Africa
Safety Observer 170EU Clinical Trials Regulation
New FDA Draft Guidance
MHRA Post-Brexit Guidance
GPvP in Brazil
CIOMS Guides
Safety Observer 169COVID-19 Guidance
New CIOMS DILI Guidance
FDA updates E2B Guidance
FDA updates REMS Guidance
EU PV Training Material
Choose the number of users for this product
Number of users
- 1 user
- 2 to 5 users
- 6 to 14 users
- 15 to 49 users
- 50 and + users
Choose the number of users for this product
Number of users
- 1 user
- 2 to 5 users
- 6 to 14 users
- 15 to 49 users
- 50 and + users
